ONMD· Health Care› Health Information Services

OneMedNet Corp Class A

Stage 4 · Declining · week 19

As of Oct 22, 2026, OneMedNet is in Stage 4, the downtrend phase, now in week 19 (since Jun 12, 2026). It closed at $4.91, 79.3% below its 52-week high and below its 200-day average, which is falling.

OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. More about the company

$4.91

+7.21% today

$28.6M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ONMD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 23w

S4 16w

S4 19w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 9w → S3 1w → S4 23w → S1 1w → S4 7w → S1 11w → S4 4w → S3 4w → S4 8w → S1 4w → S2 9w → S3 1w → S4 16w → S1 11w → S2 13w → S3 8w → S4 8w → S1 7w → S4 19w current

Total tracked: 165 weeks across 19 stage runs.

ONMD among Health Information Services36th of 41 by relative strength

All 41 →

Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	AMWLAmerican Well Corporation Class A	Stage 2 · wk 25	97	+7.4%
2	HNGEHinge Health, Inc. Class A	Stage 2 · wk 20	96	+19.1%
3	BTSGBrightSpring Health Services, Inc.	Stage 3 · wk 8	94	+9.1%
4	NRCNRC Health	Stage 3 · wk 4	93	−0.1%
5	SOPHSOPHiA GENETICS SA	Stage 2 · wk 24	91	−12.7%
6	HTFLHeartflow, Inc.	Stage 2 · wk 10	87	+17.0%
7	HSTMHealthStream, Inc.	Stage 2 · wk 17	77	+20.3%
8	OMCLOmnicell, Inc.	Stage 4 · wk 10	70	+12.5%
…36	ONMDOneMedNet Corp Class A	Stage 4 · wk 19	11	−25.0%

vs 52W High

-79.3%

$3.93 lo$23.70 hi

79.3% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 19

1w13w26w

Week 19, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-33.8%

200 DMA: $7.41 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.91x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-25.0%

-20.2%

-44.8%

YTD

-59.8%

-80.3%

Scan Membership

Breakout Watch

Latest: 2024-12-30

2 appearances in last 60 days. First seen: 2022-04-07.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 19 · Vol 0.91x

2026-10-21S4

Wk 19 · Vol 0.14x

2026-10-20S4

Wk 18 · Vol 0.14x

2026-10-19S4

Wk 18 · Vol 0.32x

2026-10-16S4

Wk 18 · Vol 0.33x

2026-10-15S4

Wk 18 · Vol 0.53x

2026-10-14S4

Wk 18 · Vol 1.98x

2026-10-13S4

Wk 17 · Vol 0.70x

2026-10-12S4

Wk 17 · Vol 0.79x

2026-10-09S4

Wk 17 · Vol 0.43x

2026-10-08S4

Wk 17 · Vol 0.29x

2026-10-07S4

Wk 17 · Vol 0.21x

Moving averages & range

50 DMA

$5.81

200 DMA

$7.41

52W High

$23.70

52W Low

$3.93

5D Low

$4.51

Resistance levels (recent highs)

20d High

$6.50

60d High

$7.81

120d High

$10.50

250d High

$23.70

Next resistance

+32.4%

to 20d High

Dividend Yield

0.00%

P/B -8.1

OneMedNet: quick answers

What stage is OneMedNet in?

As of Oct 22, 2026, OneMedNet (ONMD) is in Stage 4, the downtrend phase. It entered Stage 4 on Jun 12, 2026 and is in week 19. What the four stages mean

Is OneMedNet in an uptrend?

No. OneMedNet is in a Stage 4 downtrend. It trades 33.8% below its 200-day average, which is falling.

How far is OneMedNet from its 52-week high?

OneMedNet closed at $4.91 on Oct 22, 2026, 79.3% below its 52-week high of $23.70. Its 52-week low is $3.93.

How has OneMedNet performed over the past year?

As of Oct 22, 2026, OneMedNet is down 80.3% over the past year and down 59.8% so far in 2026.

Which sector and industry is OneMedNet in?

OneMedNet is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. It offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets. The company also provides BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered in Eden Prairie, Minnesota.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.